From Wikipedia, the free encyclopedia
Polyneuropathy
Micrograph showing peripheral neuropathy (vasculitis). Polyneuropathy is peripheral neuropathy occurring in the same areas on both sides of the body.
Specialty Neurology  Edit this on Wikidata
SymptomsAtaxia [1]
CausesHereditary ( Charcot–Marie–Tooth disease), and acquired ( alcohol use disorder) [2]
Diagnostic methodNerve conduction study, urinalysis [3] [1]
TreatmentOccupational therapy, weight decrease (management) [1]

Polyneuropathy ( poly- + neuro- + -pathy) is damage or disease affecting peripheral nerves ( peripheral neuropathy) in roughly the same areas on both sides of the body, featuring weakness, numbness, and burning pain. [1] It usually begins in the hands and feet and may progress to the arms and legs and sometimes to other parts of the body where it may affect the autonomic nervous system. It may be acute or chronic. A number of different disorders may cause polyneuropathy, including diabetes and some types of Guillain–Barré syndrome. [4] [5] [6]

Classification

Polyneuropathies may be classified in different ways, such as by cause, [2] by presentation, [1] or by classes of polyneuropathy, in terms of which part of the nerve cell is affected mainly: the axon, the myelin sheath, or the cell body. [7] [8]

Action potential propagation in myelinated neurons is faster than in unmyelinated neurons(left)

Signs and symptoms

Among the signs/symptoms of polyneuropathy, which can be divided (into sensory and hereditary) and are consistent with the following: [1]

Causes

The causes of polyneuropathy can be divided into hereditary and acquired and are therefore as follows: [2]

Pathophysiology

Human T Cell

The pathophysiology of polyneuropathy depends on the type. Chronic inflammatory demyelinating polyneuropathy, for instance, is an autoimmune disease: T cells involvement has been demonstrated, antibodies alone are not capable of demyelination. [16]

Diagnosis

Micrograph of a muscle biopsy

The diagnosis of polyneuropathy begins with a history (anamnesis) and physical examination to ascertain the pattern of the disease process (such as arms, legs, distal, proximal), if they fluctuate, and what deficits and pain are involved. If pain is a factor, determining where and how long it has been present is important; one also needs to know what disorders are present within the family and what diseases the person may have. Although diseases often are suggested by the physical examination and history alone, tests that may be employed include electrodiagnostic testing, serum protein electrophoresis, nerve conduction studies, urinalysis, serum creatine kinase (CK) and antibody testing; nerve biopsy is done sometimes. [1] [3]

Other tests may be used, especially tests for specific disorders associated with polyneuropathies; quality measures have been developed to diagnose patients with distal symmetrical polyneuropathy (DSP). [17]

Differential diagnosis

In terms of the differential diagnosis for polyneuropathy, the following must be considered:

Treatment

Methylprednisolone

In the treatment of polyneuropathies one must ascertain and manage the cause, among management activities are: weight decrease, use of a walking aid, and occupational therapist assistance. Additionally, BP control in those with diabetes is helpful, while intravenous immunoglobulin is used for multifocal motor neuropathy. [1]

According to Lopate, et al., methylprednisolone is a viable treatment for chronic inflammatory demyelinative polyneuropathy (which can also be treated with intravenous immunoglobulin). The authors also indicate that prednisone has greater adverse effects in such treatment, as opposed to intermittent (high-doses) of the aforementioned medication. [1] [21]

According to Wu, et al., in critical illness polyneuropathy supportive and preventive therapy are important for the affected individual, as well as, avoiding (or limiting) corticosteroids. [22]

See also

References

  1. ^ a b c d e f g h i "Polyneuropathies. Medical information about polyneuropathy | Patient". Patient. Retrieved 2016-07-17.
  2. ^ a b c MD, Dr Sara J. Cuccurullo (2014-11-25). Physical Medicine and Rehabilitation Board Review, Third Edition. Demos Medical Publishing. p. 434. ISBN  9781617052019. Retrieved 26 August 2016.
  3. ^ a b Burns, Ted M.; Mauermann, Michelle L. (15 February 2011). "The Evaluation of Polyneuropathies". Neurology. 76 (7 Supplement 2): S6–S13. doi: 10.1212/WNL.0b013e31820c3622. ISSN  0028-3878. PMC  5766173. PMID  21321354.
  4. ^ Richard A C Hughes (23 February 2002). "Clinical review: Peripheral neuropathy". British Medical Journal. 324 (7335): 466–469. doi: 10.1136/bmj.324.7335.466. PMC  1122393. PMID  11859051.
  5. ^ Janet M. Torpy; Jennifer L. Kincaid; Richard M. Glass (21 April 2010). "Patient page: Peripheral neuropathy". Journal of the American Medical Association. 303 (15): 1556. doi: 10.1001/jama.303.15.1556. PMID  20407067.
  6. ^ "Peripheral neuropathy fact sheet". National Institute of Neurological Disorders and Stroke. 19 September 2012.
  7. ^ Rakel, David; Rakel, Robert E. (2015-02-02). Textbook of Family Medicine. Elsevier Health Sciences. p. 1026. ISBN  9780323313087. Retrieved 26 August 2016.
  8. ^ McCance, Kathryn L.; Huether, Sue E. (2014-01-30). Pathophysiology: The Biologic Basis for Disease in Adults and Children. Elsevier Health Sciences. p. 635. ISBN  9780323316071. Retrieved 26 August 2016.
  9. ^ Perry, Michael C., ed. (2007). The chemotherapy source book (4th ed.). Philadelphia, Pa.: Lippincott Williams & Wilkins. p. 241. ISBN  9780781773287. Retrieved 26 August 2016.
  10. ^ Moloney, Elizabeth B.; de Winter, Fred; Verhaagen, Joost (14 August 2014). "ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease". Frontiers in Neuroscience. 8: 252. doi: 10.3389/fnins.2014.00252. PMC  4132373. PMID  25177267.
  11. ^ Hankey, Graeme J.; Wardlaw, Joanna M. (2008). Clinical neurology. London: Manson. p. 580. ISBN  9781840765182. Retrieved 26 August 2016.
  12. ^ Goodman, Catherine C.; Fuller, Kenda S. (2013-08-07). Pathology: Implications for the Physical Therapist. Elsevier Health Sciences. p. 1597. ISBN  9780323266468. Retrieved 26 August 2016.
  13. ^ RESERVED, INSERM US14 – ALL RIGHTS. "Orphanet: Acute inflammatory demyelinating polyradiculoneuropathy". www.orpha.net. Retrieved 2016-08-26.{{ cite web}}: CS1 maint: numeric names: authors list ( link)
  14. ^ "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Information Page: National Institute of Neurological Disorders and Stroke (NINDS)". www.ninds.nih.gov. Retrieved 2016-07-30.
  15. ^ Barohn, Richard J.; Amato, Anthony A. (May 2013). "Pattern-Recognition Approach to Neuropathy and Neuronopathy". Neurologic Clinics. 31 (2): 343–361. doi: 10.1016/j.ncl.2013.02.001. ISSN  0733-8619. PMC  3922643. PMID  23642713.
  16. ^ Mahdi-Rogers, Mohamed; Rajabally, Yusuf A (1 January 2010). "Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins". Biologics: Targets and Therapy. 4: 45–49. doi: 10.2147/btt.s4881. ISSN  1177-5475. PMC  2846143. PMID  20376173.
  17. ^ England, John D.; Franklin, Gary; Gjorvad, Gina; Swain-Eng, Rebecca; Brannagan, Thomas H.; David, William S.; Dubinsky, Richard M.; Smith, Benn E. (13 May 2014). "Quality improvement in neurology". Neurology. 82 (19): 1745–1748. doi: 10.1212/WNL.0000000000000397. ISSN  0028-3878. PMC  4032209. PMID  24696504.
  18. ^ a b c d e f g h "Polyneuropathy/differential diagnosis". BMJ.com. BMJ Best Practices. Retrieved 26 August 2016.
  19. ^ Chronic renal failure, Medline Plus
  20. ^ Koeppen, Arnulf H.; Mazurkiewicz, Joseph E. (2013). "Friedreich Ataxia: Neuropathology Revised". Journal of Neuropathology & Experimental Neurology. 72 (2): 78–90. doi: 10.1097/NEN.0b013e31827e5762. PMC  3817014. PMID  23334592.
  21. ^ Lopate, Glenn; Pestronk, Alan; Al-Lozi, Muhammad (1 February 2005). "Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With High-Dose Intermittent Intravenous Methylprednisolone". Archives of Neurology. 62 (2): 249–54. doi: 10.1001/archneur.62.2.249. ISSN  0003-9942. PMID  15710853.
  22. ^ Zhou, Chunkui; Wu, Limin; Ni, Fengming; Ji, Wei; Wu, Jiang; Zhang, Hongliang (1 January 2014). "Critical illness polyneuropathy and myopathy: a systematic review". Neural Regeneration Research. 9 (1): 101–110. doi: 10.4103/1673-5374.125337. ISSN  1673-5374. PMC  4146320. PMID  25206749.

Further reading

External links